-
134996-5GApplication 3-Iodobenzylamine hydrochloride was used as the starting reagent in the synthesis of N 6 -(3-iodobenzyl)-2-substituted-adenosine derivatives . It was used in the synthesis of 3′- C -methyl adenosine N 6 -substituted and N 6 / C -2
-
G119-100MGApplication GYKI 52466 hydrochloride has been used as an α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor selective antagonist in cell viability assays to evaluate the specificity of kainate (KA) effect on cerebellar
-
G119-10MGApplication GYKI 52466 hydrochloride has been used as an α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor selective antagonist in cell viability assays to evaluate the specificity of kainate (KA) effect on cerebellar
-
G119-25MGApplication GYKI 52466 hydrochloride has been used as an α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor selective antagonist in cell viability assays to evaluate the specificity of kainate (KA) effect on cerebellar
-
1314009-200MGThis product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the
-
BP186This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the
-
H2910-5GBiochem/physiol Actions Carbonic anhydrase inhibitor
-
H4759-100GBiochem/physiol Actions Carbonic anhydrase inhibitor
-
H4759-25GBiochem/physiol Actions Carbonic anhydrase inhibitor
-
H4759-5GBiochem/physiol Actions Carbonic anhydrase inhibitor
-
H-001-1MLHydrochlorothiazide is a calcium-sparing diuretic used for treatment of edema and hypertension. A thiazide derivative, hydrochlorothiazide is sold under the trade names Microzide ® and Aquazide H.
-
1191630001Analysis Note 20 mg/l caffeine: in accordance Legal Information LICHROTEST is a trademark of Merck KGaA, Darmstadt, Germany